stella
beta
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia — Stella
Home
/
B-ALL
/
View on ClinicalTrials.gov
Recruiting
Back to B-ALL trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
China
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China, Wuhan, Hubei